Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
BI-765049 by Boehringer Ingelheim International for Metastatic Colorectal Cancer: Likelihood of Approval
BI-765049 is under clinical development by Boehringer Ingelheim International and currently in Phase I for Metastatic Colorectal Cancer. According to...
BI-765049 by Boehringer Ingelheim International for Hepatocellular Carcinoma: Likelihood of Approval
BI-765049 is under clinical development by Boehringer Ingelheim International and currently in Phase I for Hepatocellular Carcinoma. According to GlobalData,...
BI-765049 by Boehringer Ingelheim International for Pancreatic Cancer: Likelihood of Approval
BI-765049 is under clinical development by Boehringer Ingelheim International and currently in Phase I for Pancreatic Cancer. According to GlobalData,...
BI-765049 by Boehringer Ingelheim International for Head And Neck Squamous Cell Carcinoma (HNSC): Likelihood of Approval
BI-765049 is under clinical development by Boehringer Ingelheim International and currently in Phase I for Head And Neck Squamous Cell...
BI-765049 by Boehringer Ingelheim International for Non-Small Cell Lung Cancer: Likelihood of Approval
BI-765049 is under clinical development by Boehringer Ingelheim International and currently in Phase I for Non-Small Cell Lung Cancer. According...